Increased levels of serum granulocyte-macrophage colony-stimulating factor is associated with activated peripheral dendritic cells in type 2 diabetes subjects (CURES-99)

Diabetes Technology and Therapeutics

Volumn 14, Issue 4, 2012, Pages 344-349

  Surendar, Jayagopi ^a   Mohan, Viswanathan ^a   Pavankumar, Nathella ^b   Babu, Subash ^b   Aravindhan, Vivekanandhan ^c  

^a MADRAS DIABETES RESEARCH FOUNDATION   (India)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

^c ANNA UNIVERSITY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOSYLATED HEMOGLOBIN; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INSULIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; ORAL ANTIDIABETIC AGENT; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ANTIGEN EXPRESSION; ARTICLE; CELL ACTIVATION; CLINICAL ARTICLE; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DENDRITIC CELL; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; MALE; MONOTHERAPY; NON INSULIN DEPENDENT DIABETES MELLITUS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; QUANTITATIVE ANALYSIS;

ADULT; DENDRITIC CELLS; DIABETES MELLITUS, TYPE 2; FEMALE; FLOW CYTOMETRY; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HUMANS; INDIA; INTERLEUKIN-1BETA; INTERLEUKIN-6; MALE; SAMPLING STUDIES; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION;

EID: 84859316049     PISSN: 15209156     EISSN: 15578593     Source Type: Journal    
DOI: 10.1089/dia.2011.0182     Document Type: Article

References (23)

1. Dandona P, Aljada A, Bandyopadhyay A: Inflammation: The link between insulin resistance, obesity and diabetes. Trends Immunol 2004;25:4-7. (Pubitemid 38032801)
2. Navarro-Gonzalez JF, Mora-Fernandez C: The role of inflammatory cytokines in diabetic nephropathy. J Am Soc Nephrol 2008;19:433-442. (Pubitemid 351355386)
3. Adamis AP: Is diabetic retinopathy an inflammatory disease? Br J Ophthalmol 2002;86:363-365. (Pubitemid 34293277)
4. Duncan BB, Schmidt MI, Pankow JS, Ballantyne CM, Couper D, Vigo A, Hoogeveen R, Folsom AR, Heiss G: Low-grade systemic inflammation and the development of type 2 diabetes: The Atherosclerosis Risk in Communities Study. Diabetes 2003;52:1799-1805. (Pubitemid 36792473)
5. Hussain MJ, Peakman M, Gallati H, Lo SS, Hawa M, Viberti GC, Watkins PJ, Leslie RD, Vergani D: Elevated serum levels of macrophage-derived cytokines precede and accompany the onset of IDDM. Diabetologia 1996;39:60-69. (Pubitemid 26029733)
6. Gokulakrishnan K, Deepa R, Mohan V: Association of high sensitivity C-reactive protein (hsCRP) and tumour necrosis factor-alpha (TNF-alpha) with carotid intimal medial thickness in subjects with different grades of glucose intolerance the Chennai Urban Rural Epidemiology Study (CURES-31). Clin Biochem 2008;41:480-485.
7. Deepa R, Velmurugan K, Arvind K, Sivaram P, Sientay C, Uday S, Mohan V: Serum levels of interleukin 6, C-reactive protein, vascular cell adhesion molecule 1, and monocyte chemotactic protein 1 in relation to insulin resistance and glucose intolerance the Chennai Urban Rural Epidemiology Study (CURES). Metabolism 2006;55:1232-1238. (Pubitemid 44215943)
8. Schreurs MW, Eggert AA, de Boer AJ, Figdor CG, Adema GJ: Generation and functional characterization of mouse monocyte-derived dendritic cells. Eur J Immunol 1999;29: 2835-2841. (Pubitemid 30099008)
9. Conti L, Gessani S: GM-CSF in the generation of dendritic cells from human blood monocyte precursors: recent advances. Immunobiology 2008;213:859-870.
10. Reed JA, Clegg DJ, Smith KB, Tolod-Richer EG, Matter EK, Picard LS, Seeley RJ: GM-CSF action in the CNS decreases food intake and body weight. J Clin Invest 2005;115:3035-3044. (Pubitemid 41567569)
11. Steinman RM, Hemmi H: Dendritic cells: translating innate to adaptive immunity. Curr Top Microbiol Immunol 2006; 311:17-58. (Pubitemid 47413194)
12. Reis e Sousa C: Activation of dendritic cells: translating innate into adaptive immunity. Curr Opin Immunol 2004;16: 21-25. (Pubitemid 38198114)
13. Eksioglu EA, Mahmood SS, Chang M, Reddy V: GM-CSF promotes differentiation of human dendritic cells and T lymphocytes toward a predominantly type 1 proinflammatory response. Exp Hematol 2007;35:1163-1171. (Pubitemid 47088777)
14. Deepa M, Pradeepa R, Rema M, Mohan A, Deepa R, Shanthirani S, Mohan V: The Chennai Urban Rural Epidemiology Study (CURES) study design and methodology (urban component) (CURES-I). J Assoc Physicians India 2003;51: 863-870. (Pubitemid 41279865)
15. Fida S, Myers M, Mackay IR, Zimmet PZ, Mohan V, Deepa R, Rowley MJ: Antibodies to diabetes-associated autoantigens in Indian patients with Type 1 diabetes: prevalence of anti-ICA512/IA2 and anti-SOX13. Diabetes Res Clin Pract 2001;52:205-211. (Pubitemid 32385333)
16. Summers KL, Marleau AM, Mahon JL, McManus R, Hramiak I, Singh B: Reduced IFN-alpha secretion by blood dendritic cells in human diabetes. Clin Immunol 2006;121: 81-89. (Pubitemid 44380413)
17. Corrales JJ, Almeida M, Burgo RM, Hernandez P, Miralles JM, Orfao A: Decreased production of inflammatory cytokines by circulating monocytes and dendritic cells in type 2 diabetic men with atherosclerotic complications. J Diabetes Complications 2007;21:41-49. (Pubitemid 44960839)
18. Seifarth CC, Hinkmann C, Hahn EG, Lohmann T, Harsch IA: Reduced frequency of peripheral dendritic cells in type 2 diabetes. Exp Clin Endocrinol Diabetes 2008;116:162-166. (Pubitemid 351518535)
19. Blank SE, Johnson EC, Weeks DK, Wysham CH: Circulating dendritic cell number and intracellular TNF-a production in women with type 2 diabetes. Acta Diabetol 2010 May 7. [Epub ahead of print]. DOI: 10.1007/s00592-010-0190-8.
20. Andersson CX, Sopasakis VR, Wallerstedt E, Smith U: Insulin antagonizes interleukin-6 signaling and is antiinflammatory in 3T3-L1 adipocytes. J Biol Chem 2007;282: 9430-9435. (Pubitemid 47104618)
21. Nakamura A, Shikata K, Hiramatsu M, Nakatou T, Kitamura T, Wada J, Itoshima T, Makino H: Serum interleukin-18 levels are associated with nephropathy and atherosclerosis in Japanese patients with type 2 diabetes. Diabetes Care 2005;28:2890-2895. (Pubitemid 43942920)
22. Joya-Galeana J, Fernandez M, Cervera A, Reyna S, Ghosh S, Triplitt C, Musi N, DeFronzo RA, Cersosimo E: Effects of insulin and oral anti-diabetic agents on glucose metabolism, vascular dysfunction and skeletal muscle inflammation in type 2 diabetic subjects. Diabetes Metab Res Rev 2011;27: 373-382.
23. Helmersson J, Vessby B, Larsson A, Basu S: Association of type 2 diabetes with cyclooxygenase-mediated inflammation and oxidative stress in an elderly population. Circulation 2004;109:1729-1734. (Pubitemid 38500674)